Stereotaxis (STXS) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual Meeting scheduled for May 15, 2025, at company headquarters in St. Louis, Missouri.
Shareholders will vote on electing two Class III directors and ratifying Ernst & Young LLP as the independent auditor for 2025.
Proxy materials and the 2024 Annual Report are available online, with multiple voting methods offered.
Voting matters and shareholder proposals
Shareholders will elect two Class III directors to serve until the 2028 Annual Meeting.
Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year 2025 is on the agenda.
Shareholders may submit proposals for the 2026 Annual Meeting by December 5, 2025, for inclusion in proxy materials.
Board of directors and corporate governance
Board consists of nine directors divided into three staggered classes, with annual elections for one class.
Board leadership combines CEO and Chairman roles, with a lead independent director providing oversight.
All directors except David L. Fischel and Dr. Nathan Fischel are considered independent.
Committees include Audit, Compensation, and Nominating & Corporate Governance, each with written charters.
Director nomination process emphasizes integrity, independence, and diverse professional backgrounds.
Latest events from Stereotaxis
- Shelf registration enables up to $150 million in offerings to fund growth, with significant dilution risk.STXS
Registration Filing13 Mar 2026 - 2025 revenue rose 36% in Q4 and 20% for the year, with strong growth and margin expansion ahead.STXS
Q4 20259 Mar 2026 - Q2 revenue fell 43% on system delays, but regulatory wins and APT deal set up a stronger H2.STXS
Q2 20241 Feb 2026 - Q3 revenue up 18% to $9.2M, with strong cash and regulatory progress, but net loss widened.STXS
Q3 202415 Jan 2026 - Up to 6.1M shares registered for resale post-APT acquisition; earnout shares tied to milestones.STXS
Registration Filing16 Dec 2025 - Up to 6.1M shares registered for resale post-acquisition, with potential dilution from earnout shares.STXS
Registration Filing16 Dec 2025 - Q4 revenue up 39% YoY; regulatory wins and new launches drive growth outlook for 2025-26.STXS
Q4 20243 Dec 2025 - Vote on director elections and auditor ratification by May 14, 2025, via multiple methods.STXS
Proxy Filing1 Dec 2025 - Q1 2025 revenue up 9% to $7.5M, driven by recurring revenue and MAGIC launch in Europe.STXS
Q1 202526 Nov 2025